SNWV

#4347
SANUWAVE Health, Inc. - Common Stock
4.8 2 USD
+0.03%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
4.67
4.84
Jahresspanne
4.50
25.62
Tagesänderung
+2.99%
Monatliche Änderung
-21.88%
6 month change
-79.92%
Jahresänderung
-80.06%
Vorheriger Schlusskurs
4.6 8
Open
4.6 7
Tief
4.6 7
Hoch
4.8 4
Volumen
19
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Documents

2026

Current report, Q3 FY2026
SANUWAVE Health, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
SANUWAVE Health, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
SANUWAVE Health, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
SANUWAVE Health, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
SANUWAVE Health, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
SANUWAVE Health, Inc. current report, Q1 FY2026
8-K

SANUWAVE Health, Inc. current report, Q3 FY2024

Full document

Business Context and Reporting Period

Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 13, 2024
Reporting Period: Second quarter ended June 30, 2024

This filing serves as a notification that the Company issued a press release announcing its financial results for the second quarter of 2024. A business update conference call was scheduled for August 13, 2024.

Key Financial Metrics

The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The following metrics are not disclosed in this document:

  • Revenue: Not provided in filing text.
  • Profit/Loss: Not provided in filing text.
  • Cash Flow: Not provided in filing text.
  • Margins: Not provided in filing text.
  • Debt and Liquidity: Not provided in filing text.

Investors are directed to the attached press release (Exhibit 99.1) and the Company's website for detailed financial figures.

Material Changes

The filing text does not provide specific details regarding material changes in financial condition or operations compared to the prior period. It only confirms the announcement of Q2 2024 results.

Guidance, Outlook, and Risks

Management Commentary: The Company announced a business update via conference call on the date of the filing. Materials are available on the investor relations website.
Forward-Looking Statements: The filing explicitly states that the information in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference in any filing under the Securities Act of 1933, except as expressly set forth by specific reference.
Risks and Contingencies: No specific risks or contingencies are detailed in this cover document.

Investor Verification Checklist

  • Review the attached Press Release (Exhibit 99.1) for actual Q2 2024 revenue, net income, and cash flow figures.
  • Access the Company website (www.sanuwave.com/investors) for the full business update materials and conference call details.
  • Verify the XBRL data (Exhibit 104) for structured financial data if available in the full filing package.
  • Note that the financial information in this 8-K is not incorporated by reference into other SEC filings unless specifically cited.